Edition:
United Kingdom

Cytosorbents Corp (CTSO.OQ)

CTSO.OQ on NASDAQ Stock Exchange Capital Market

7.33USD
22 Jul 2019
Change (% chg)

$-0.16 (-2.14%)
Prev Close
$7.49
Open
$7.49
Day's High
$7.58
Day's Low
$7.31
Volume
30,908
Avg. Vol
32,894
52-wk High
$14.90
52-wk Low
$5.86

About

CytoSorbents Corporation is a critical care focused immunotherapy company. The Company is engaged in commercializing its product, CytoSorb, which is a blood purification technology with focus in preventing or treating multiple organ failure. The Company's purification technologies are based on biocompatible, porous polymer beads... (more)

Overall

Beta: -0.59
Market Cap(Mil.): $173.02
Shares Outstanding(Mil.): 28.13
Dividend: --
Yield (%): --

Financials

  CTSO.OQ Industry Sector
P/E (TTM): -- 191.93 32.67
EPS (TTM): -0.37 -- --
ROI: -77.87 9.69 14.49
ROE: -162.40 15.57 15.79

Earnings vs. Estimates